Olanzapine/risperidone and diabetes risk

被引:1
|
作者
Lee, DW [1 ]
Fowler, RB [1 ]
机构
[1] Protocare Sci, Herndon, VA USA
关键词
D O I
10.4088/JCP.v64n0718a
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:847 / 848
页数:2
相关论文
共 50 条
  • [22] Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine
    Fuller, MA
    Shermock, KM
    Secic, M
    Grogg, AL
    PHARMACOTHERAPY, 2003, 23 (08): : 1037 - 1043
  • [23] Reducing violence risk in persons with schizophrenia: Olanzapine versus risperidone
    Swanson, JW
    Swartz, MS
    Elbogen, EB
    Van Dorn, RA
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (12) : 1666 - 1673
  • [24] Risperidone versus olanzapine for schizophrenia
    Jayaram, MB
    Hosalli, P
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (02):
  • [25] Economic evaluations of olanzapine and risperidone
    Shaw, JW
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (14) : 1366 - 1375
  • [26] Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia
    Kasper, S
    Hale, A
    Azorin, JM
    Möller, HJ
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1999, 249 : 2 - 14
  • [28] Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia
    Siegfried Kasper
    Anthony Hale
    Jean-Michel Azorin
    Hans-Jürgen Müller
    European Archives of Psychiatry and Clinical Neuroscience, 1999, 249 (Suppl 2) : S1 - S14
  • [29] Comparative risk of parkinsonism associated with olanzapine, risperidone and quetiapine in older adults
    Chyou, Te-yuan
    Nishtala, Revathi
    Nishtala, Prasad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 479 - 480
  • [30] Risperidone versus olanzapine for schizophrenia
    Jayaram, M. B.
    Hosalli, P.
    Stroup, S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (02):